World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
67
Citations
15717
World Ranking
2890
National Ranking
278

Overview

David M. Bowen was affiliated with the University of Oxford in the United Kingdom. Their research spanned several interconnected fields, primarily focusing on medicine and neuroscience, with specific attention to cognitive neuroscience, cardiology and cardiovascular medicine, neurology, surgery, and urology.

The scientist contributed to studies across multiple domains, addressing topics such as neural dynamics and brain function, EEG and brain-computer interfaces, vestibular and auditory disorders, cardiovascular function and risk factors, urological disorders and treatments, renal and related cancers, and congenital gastrointestinal and neural anomalies.

Their work was published in a variety of scientific venues, including Science Advances, American Journal of Medical Genetics Part A, Clinical Research in Cardiology, European Heart Journal - Cardiovascular Imaging, and bioRxiv (Cold Spring Harbor Laboratory).

Among their recent papers, notable publications included:

  • "Cortico-cerebellar coordination facilitates neuroprosthetic control," 2024, Science Advances
  • "LUMBAR syndrome-OEIS complex overlap: A case series and review," 2024, American Journal of Medical Genetics Part A
  • "Prognostic value of temporal patterns of left atrial reservoir strain in patients with heart failure with reduced ejection fraction," 2023, Clinical Research in Cardiology
  • "P802 Delayed time to peak left ventricular outflow tract velocity is associated with symptomatic status in patients with hypertrophic obstructive cardiomyopathy," 2020, European Heart Journal - Cardiovascular Imaging
  • "Cortico-cerebellar coordination facilitates neuroprosthetic control," 2022, bioRxiv (Cold Spring Harbor Laboratory)

David M. Bowen collaborated frequently with several coauthors, including Aamir Abbasi, Rohit Rangwani, Andrew W. Fealy, Nathan P. Danielsen, and Tanuj Gulati. These partnerships were reflected in multiple joint publications.

Best Publications

  • Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

    David M. Bowen;Carolyn B. Smith;Pamela White;Alan N. Davison

  • Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

    G.K. Wilcock;M.M. Esiri;D.M. Bowen;C.C.T. Smith

  • NEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE

    P. White;M.J. Goodhardt;J.P. Keet;C.R. Hiley

  • Presynaptic Cholinergic Dysfunction in Patients with Dementia

    N. R. Sims;D. M. Bowen;S. J. Allen;C. C. T. Smith

  • Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.

    D. M. Bowen;S. J. Allen;J. S. Benton;M. J. Goodhardt

  • Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

    Paul T. Francis;Alan M. Palmer;Neil R. Sims;David M. Bowen

  • ACCELERATED AGEING OR SELECTIVE NEURONAL LOSS AS AN IMPORTANT CAUSE OF DEMENTIA

    J.A Spillane;G Curzon;W Meier-Ruge;P White

  • Alzheimer's disease: a correlative study.

    D Neary;J S Snowden;D M Mann;D M Bowen

  • Cortical Pyramidal Neurone Loss May Cause Glutamatergic Hypoactivity and Cognitive Impairment in Alzheimer's Disease: Investigative and Therapeutic Perspectives

    Paul T. Francis;Neil R. Sims;Andrew W. Procter;David M. Bowen

  • Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients

    D.M. Bowen;J.S. Benton;J.A. Spillane;C.C.T. Smith

  • Presynaptic serotonergic dysfunction in patients with Alzheimer's disease.

    A. M. Palmer;P. T. Francis;J. S. Benton;N. R. Sims

  • Neuropsychological syndromes in presenile dementia due to cerebral atrophy.

    D Neary;J S Snowden;D M Bowen;N R Sims

  • GLUCOSE METABOLISM AND ACETYLCHOLINE SYNTHESIS IN RELATION TO NEURONAL ACTIVITY IN ALZHEIMER'S DISEASE

    N.R. Sims;C.C.T. Smith;A.N. Davison;D.M. Bowen

  • Evidence of Glutamatergic Denervation and Possible Abnormal Metabolism in Alzheimer's Disease

    A. W. Procter;A. M. Palmer;P. T. Francis;S. L. Lowe

  • Mitochondrial function in brain tissue in primary degenerative dementia

    N.R. Sims;J.M. Finegan;J.P. Blass;D.M. Bowen

  • Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.

    Alan M. Palmer;Gary C. Stratmann;Andrew W. Procter;David M. Bowen

  • Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease

    Alan M. Palmer;Gordon K. Wilcock;Margaret M. Esiri;Paul T. Francis

  • THE NUCLEUS BASALIS IN ALZHEIMER'S DISEASE: CELL COUNTS AND CORTICAL BIOCHEMISTRY

    G K Wilcock;M M Esiri;D M Bowen;C C T Smith

  • Biochemical Evidence of Selective Nerve Cell Changes in the Normal Ageing Human and Rat Brain

    S. J. Allen;J. S. Benton;M. J. Goodhardt;E. A. Haan

  • Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.

    David M. Bowen;Abdolrahman Najlerahim;Andrew W. Procter;Paul T. Francis

  • Increased transmitter amino acid concentration in human ventricular CSF after brain trauma.

    Alan M. Palmer;Donald W. Marion;Michelle L. Botscheller;David M. Bowen

Frequent Co-Authors

Paul T. Francis
Paul T. Francis University of Exeter
Alan M. Palmer
Alan M. Palmer Elixa MediScience
Margaret M. Esiri
Margaret M. Esiri University of Oxford
John P. Blass
John P. Blass Cornell University
Rudolph E. Tanzi
Rudolph E. Tanzi Harvard University
Steven T. DeKosky
Steven T. DeKosky University of Florida
Julie S. Snowden
Julie S. Snowden University of Manchester
John G. R. Jefferys
John G. R. Jefferys University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing David M. Bowen